Header Logo

John Zajecka

Concepts (246)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Depressive Disorder, Major
29
2022
103
4.930
Why?
Antidepressive Agents
26
2023
98
3.370
Why?
Depressive Disorder
30
2007
184
2.820
Why?
Bipolar Disorder
14
2017
109
2.150
Why?
Depressive Disorder, Treatment-Resistant
6
2023
10
1.990
Why?
Antidepressive Agents, Second-Generation
13
2010
28
1.350
Why?
Psychiatric Status Rating Scales
26
2020
328
1.140
Why?
Ketamine
2
2023
25
0.980
Why?
Fluoxetine
15
2009
34
0.950
Why?
Antipsychotic Agents
9
2016
65
0.940
Why?
Secondary Prevention
16
2020
54
0.860
Why?
Triazoles
7
2003
29
0.840
Why?
Double-Blind Method
29
2020
424
0.830
Why?
Vagus Nerve Stimulation
2
2022
8
0.760
Why?
Tetrahydrofolates
3
2016
3
0.750
Why?
Valproic Acid
5
2008
13
0.730
Why?
Substance Withdrawal Syndrome
6
2003
33
0.710
Why?
Treatment Outcome
34
2022
3531
0.710
Why?
Depression
7
2022
453
0.690
Why?
Humans
78
2023
28117
0.650
Why?
Cyclohexanols
9
2010
18
0.630
Why?
Drug Therapy, Combination
15
2019
184
0.600
Why?
Adult
45
2019
8036
0.580
Why?
Suicidal Ideation
1
2017
8
0.560
Why?
Sexual Dysfunctions, Psychological
5
2005
10
0.560
Why?
Male
56
2020
15173
0.540
Why?
Female
54
2020
15583
0.520
Why?
Middle Aged
36
2020
9188
0.500
Why?
Piperazines
11
2015
80
0.500
Why?
Electroconvulsive Therapy
3
2017
16
0.460
Why?
Folic Acid
2
2016
21
0.410
Why?
Anxiety Disorders
4
2002
170
0.390
Why?
Drug Administration Schedule
15
2007
165
0.380
Why?
Acetamides
1
2010
3
0.350
Why?
Dose-Response Relationship, Drug
10
2020
351
0.340
Why?
Sexual Behavior
2
2002
57
0.330
Why?
Pirenzepine
3
2003
5
0.320
Why?
Adolescent
13
2015
2291
0.290
Why?
Personality Inventory
5
2012
75
0.280
Why?
Acute Disease
7
2013
204
0.280
Why?
Antimanic Agents
1
2006
8
0.280
Why?
Social Adjustment
2
2010
27
0.260
Why?
Administration, Intranasal
2
2023
27
0.250
Why?
Sertraline
5
2006
24
0.250
Why?
Aged
17
2016
9223
0.240
Why?
Chronic Disease
6
2017
441
0.240
Why?
Remission Induction
5
2020
90
0.230
Why?
Surveys and Questionnaires
5
2015
1201
0.230
Why?
Venlafaxine Hydrochloride
9
2010
17
0.230
Why?
Obsessive-Compulsive Disorder
4
2006
19
0.220
Why?
Placebos
7
2006
70
0.220
Why?
Prospective Studies
4
2017
1763
0.220
Why?
Obesity
3
2015
311
0.210
Why?
Recurrence
5
2016
318
0.210
Why?
Ambulatory Care
7
2008
73
0.200
Why?
Follow-Up Studies
7
2017
1811
0.190
Why?
Young Adult
5
2016
2048
0.190
Why?
Combined Modality Therapy
6
2020
306
0.180
Why?
Receptors, Opioid, kappa
1
2020
2
0.170
Why?
Pyrrolidines
1
2020
11
0.170
Why?
Narcotic Antagonists
1
2020
10
0.170
Why?
Benzamides
1
2020
15
0.170
Why?
Quality of Life
5
2010
656
0.170
Why?
Patient Compliance
5
2007
163
0.150
Why?
Psychotic Disorders
2
2001
44
0.150
Why?
Long-Term Care
2
2016
58
0.150
Why?
Thiazoles
2
2012
19
0.150
Why?
Antidepressive Agents, Tricyclic
3
2004
15
0.150
Why?
Severity of Illness Index
6
2007
991
0.140
Why?
C-Reactive Protein
2
2015
105
0.140
Why?
Phenethylamines
1
2016
1
0.140
Why?
Pyridines
1
2016
37
0.130
Why?
Comorbidity
6
2015
497
0.130
Why?
Randomized Controlled Trials as Topic
2
2011
320
0.130
Why?
Glutamates
1
2015
9
0.130
Why?
Registries
1
2017
182
0.130
Why?
Serotonin
2
1997
24
0.130
Why?
Psychometrics
5
2012
243
0.130
Why?
Dizziness
4
2007
18
0.130
Why?
Sexual Dysfunction, Physiological
2
2007
4
0.120
Why?
Hypericum
2
2005
3
0.120
Why?
Paroxetine
4
2007
14
0.120
Why?
Phytotherapy
2
2005
11
0.120
Why?
Sulfides
1
2015
11
0.120
Why?
Anti-Anxiety Agents
1
2015
39
0.120
Why?
S-Adenosylhomocysteine
1
2014
1
0.120
Why?
Aldehydes
1
2014
2
0.120
Why?
S-Adenosylmethionine
1
2014
5
0.120
Why?
Administration, Oral
2
2019
110
0.110
Why?
Vagus Nerve
2
2022
14
0.110
Why?
Nausea
3
1999
24
0.110
Why?
Inflammation
1
2015
288
0.110
Why?
Diagnosis, Differential
2
2007
370
0.110
Why?
Sleep Initiation and Maintenance Disorders
3
2000
105
0.100
Why?
Anticonvulsants
2
2003
56
0.100
Why?
Hypertension
2
2007
225
0.100
Why?
Tranylcypromine
1
1991
2
0.100
Why?
Prevalence
1
2013
466
0.090
Why?
Multicenter Studies as Topic
1
2011
52
0.090
Why?
Reproducibility of Results
4
2005
715
0.090
Why?
Headache
3
2007
33
0.090
Why?
Orgasm
1
1991
10
0.090
Why?
Patient Education as Topic
3
2003
161
0.090
Why?
Fever
1
1991
36
0.090
Why?
Attitude to Health
2
2002
106
0.090
Why?
Duloxetine Hydrochloride
2
2015
9
0.090
Why?
Rhabdomyolysis
1
2010
7
0.090
Why?
Electroencephalography
1
2010
80
0.080
Why?
Patient Selection
1
2011
207
0.080
Why?
Choice Behavior
1
2010
47
0.080
Why?
Tachyphylaxis
1
2009
1
0.080
Why?
Delayed-Action Preparations
4
2010
28
0.080
Why?
Benzodiazepines
3
2003
48
0.080
Why?
Sleep Stages
2
1999
26
0.080
Why?
Cognition Disorders
1
2015
1019
0.070
Why?
1-Naphthylamine
2
1997
4
0.070
Why?
Ribavirin
1
2007
10
0.070
Why?
Interferon-alpha
1
2007
32
0.070
Why?
Half-Life
2
1997
11
0.070
Why?
Serotonin Antagonists
2
2001
8
0.070
Why?
Syndrome
2
1997
81
0.070
Why?
Hepatitis C, Chronic
1
2007
42
0.070
Why?
Adrenergic Uptake Inhibitors
2
2004
6
0.070
Why?
Analysis of Variance
4
2010
275
0.070
Why?
Antiviral Agents
1
2007
71
0.070
Why?
Substance-Related Disorders
1
2007
90
0.060
Why?
Weight Gain
3
2001
63
0.060
Why?
Electric Stimulation Therapy
1
2005
43
0.060
Why?
Sex Factors
2
2005
475
0.060
Why?
Retrospective Studies
4
2007
3537
0.060
Why?
Thiophenes
1
2004
10
0.060
Why?
Morpholines
1
2003
12
0.050
Why?
Psychotherapy
1
2003
42
0.050
Why?
Health Status
3
2003
227
0.050
Why?
Drug Tolerance
1
2002
7
0.050
Why?
Body Weight
2
2002
141
0.050
Why?
Patient Care Planning
1
2003
52
0.050
Why?
Personal Satisfaction
1
2002
46
0.050
Why?
Biomarkers
2
2015
583
0.050
Why?
Drug Interactions
2
1991
38
0.050
Why?
Mianserin
1
2001
8
0.050
Why?
Buspirone
1
2001
4
0.050
Why?
Bupropion
1
2001
6
0.050
Why?
Sildenafil Citrate
1
2001
11
0.050
Why?
Sulfones
1
2001
20
0.050
Why?
Psychomotor Agitation
1
2001
14
0.050
Why?
Sexuality
1
2001
15
0.050
Why?
Telephone
1
2000
29
0.040
Why?
Central Nervous System Stimulants
1
2001
40
0.040
Why?
Self Disclosure
1
2000
7
0.040
Why?
Purines
1
2001
42
0.040
Why?
Asthenia
1
2000
1
0.040
Why?
Desipramine
1
2000
3
0.040
Why?
Feeding and Eating Disorders
1
2000
12
0.040
Why?
Nasal Sprays
1
2019
3
0.040
Why?
Practice Guidelines as Topic
1
2002
316
0.040
Why?
Behavior Therapy
1
2000
89
0.040
Why?
Sensitivity and Specificity
1
2000
511
0.040
Why?
Drug Synergism
2
1995
41
0.040
Why?
Anxiety
1
1999
156
0.040
Why?
Prognosis
1
2000
819
0.040
Why?
Fluvoxamine
1
1997
2
0.040
Why?
MEDLINE
1
1997
4
0.040
Why?
Sensation Disorders
1
1997
11
0.040
Why?
Abbreviations as Topic
1
1997
1
0.030
Why?
Paresthesia
1
1997
2
0.030
Why?
Receptors, Serotonin
1
1997
12
0.030
Why?
Treatment Refusal
1
1997
11
0.030
Why?
Neurotransmitter Agents
1
1997
17
0.030
Why?
Norepinephrine
1
1997
29
0.030
Why?
Life Change Events
1
1997
38
0.030
Why?
Time Factors
3
2010
1489
0.030
Why?
Medical Records
1
1997
34
0.030
Why?
Medical History Taking
1
1997
30
0.030
Why?
Quetiapine Fumarate
1
2016
3
0.030
Why?
Down-Regulation
1
1997
101
0.030
Why?
Triazines
1
2016
12
0.030
Why?
Imipramine
1
1996
10
0.030
Why?
Clinical Trials as Topic
1
1997
234
0.030
Why?
Family Practice
1
1996
15
0.030
Why?
Community Mental Health Services
1
1996
19
0.030
Why?
Drug Resistance
2
2006
47
0.030
Why?
Adiponectin
1
2015
10
0.030
Why?
Heterocyclic Compounds
1
1995
8
0.030
Why?
Leptin
1
2015
22
0.030
Why?
Primary Health Care
1
1997
98
0.030
Why?
Interleukin-6
1
2015
79
0.030
Why?
Infant
1
1997
591
0.030
Why?
Plant Extracts
2
2005
15
0.030
Why?
Infant, Newborn
1
1997
660
0.030
Why?
Terminology as Topic
1
1995
32
0.030
Why?
Affect
1
1995
60
0.030
Why?
Mental Disorders
1
1997
181
0.030
Why?
Phobic Disorders
1
1995
66
0.030
Why?
Tumor Necrosis Factor-alpha
1
2015
193
0.030
Why?
Incidence
1
1997
757
0.030
Why?
Panic Disorder
1
1995
133
0.030
Why?
Carbamazepine
1
1993
6
0.030
Why?
Lithium
1
1993
19
0.030
Why?
Multiple Sclerosis
1
1995
103
0.030
Why?
Genotype
1
2014
346
0.030
Why?
Child
1
1997
1410
0.030
Why?
Chemotherapy, Adjuvant
1
2012
81
0.030
Why?
Amitriptyline
1
1991
3
0.020
Why?
Sympathomimetics
1
1991
5
0.020
Why?
Pemoline
1
1991
1
0.020
Why?
Dextroamphetamine
1
1991
2
0.020
Why?
Monoamine Oxidase Inhibitors
1
1991
17
0.020
Why?
Iatrogenic Disease
1
1991
28
0.020
Why?
Neuropsychological Tests
1
2015
1258
0.020
Why?
Risk Factors
1
1997
2375
0.020
Why?
Drugs, Investigational
1
1990
6
0.020
Why?
Single-Blind Method
1
2010
111
0.020
Why?
Hospitalization
1
1991
320
0.020
Why?
Kaplan-Meier Estimate
1
2009
178
0.020
Why?
Drug Evaluation
1
2007
20
0.020
Why?
Respiratory Tract Infections
1
2007
24
0.020
Why?
Gastrointestinal Diseases
1
2007
36
0.020
Why?
Outpatients
1
2007
59
0.020
Why?
Chi-Square Distribution
1
2006
145
0.020
Why?
Longitudinal Studies
1
2010
1368
0.020
Why?
Endpoint Determination
1
2005
22
0.020
Why?
Mood Disorders
1
2005
29
0.020
Why?
Reference Values
1
2005
201
0.020
Why?
Stress, Psychological
1
2007
245
0.010
Why?
Eligibility Determination
1
2003
3
0.010
Why?
United States
1
2010
2161
0.010
Why?
Case-Control Studies
1
2005
585
0.010
Why?
Cross-Over Studies
1
2003
64
0.010
Why?
Health Services
1
2003
8
0.010
Why?
Survival Analysis
1
2003
265
0.010
Why?
Health Care Costs
1
2003
79
0.010
Why?
Priapism
1
2002
11
0.010
Why?
Suicide
1
2002
15
0.010
Why?
Seizures
1
2002
67
0.010
Why?
Patient Dropouts
1
2001
28
0.010
Why?
Injections, Intramuscular
1
2001
7
0.010
Why?
Area Under Curve
1
2001
62
0.010
Why?
Schizophrenic Psychology
1
2001
26
0.010
Why?
Treatment Failure
1
2001
162
0.010
Why?
Schizophrenia
1
2001
67
0.010
Why?
Patient Satisfaction
1
2003
321
0.010
Why?
Appetite
1
1999
4
0.010
Why?
Age Factors
1
2002
790
0.010
Why?
Weight Loss
1
1999
126
0.010
Why?
Body Mass Index
1
1999
435
0.010
Why?
Zajecka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (246)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_